The company’s turnover reported a 12-fold hike in the five years of activity on the Romanian market.
According to the Romanian Association of Licensed Stem Cell Banks (ARBACS), 6% of Romanian families decided to sample and store stem cells last year, from 5% a year before.
In 2012, the stem cell market was estimated at EUR15 million.
ARBACS includes three companies: Biogenis, Cord Blood Center and Stem Sure, which own together a 70% stake on the Romanian stem cell market, estimated to increase to 75% this year.
The total number of stem cell banks in Romania currently stands at 18.